Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AMRX | STVN | ORKA | ||
| Company | Amneal Pharmaceuticals Inc | Stevanato Group S.P.A. | Oruka Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 16.85 | 19.37 | 84.94 | ||
| High | 17.34 | 19.89 | 85.83 | ||
| Low | 16.82 | 19.37 | 82.53 | ||
| Latest | 17.18 | 19.78 | 84.56 | ||
| Change | +0.17 | +0.19 | -2.23 | ||
| % Change | +1.00% | +0.97% | -2.57% | ||
| Volume | 3,009,900 | 174,200 | 769,700 | ||
| 20-Day Average Volume | 2,345,215 | 353,685 | 1,811,180 | ||
| Previous Close | 17.01 | 19.59 | 86.79 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 16.83 | 18.11 | 82.78 | ||
| 20-Day Raw Stochastic | 68.08% | 87.75% | 57.49% | ||
| 20-Day Relative Strength | 70.03 | 62.62 | 58.67 | ||
| Weighted Alpha | +110.95 | -12.80 | +403.60 | ||
| Today's Opinion | 100% Buy | 56% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 40% Buy | 100% Buy | ||
| Last Month's Opinion | 56% Buy | 16% Sell | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.54% since 07/06/26 | +2.59% since 07/06/26 | +1.72% since 07/06/26 | ||
| Low | 16.45 on 07/08/26 | 18.72 on 07/08/26 | 81.15 on 07/08/26 | ||
| High | 17.42 on 07/07/26 | 20.27 on 07/10/26 | 89.85 on 07/07/26 | ||
| 1-Month | |||||
| %Chg | +6.05% since 06/12/26 | +15.81% since 06/12/26 | +20.99% since 06/12/26 | ||
| Low | 15.73 on 06/15/26 | 16.27 on 06/16/26 | 66.68 on 06/16/26 | ||
| High | 17.86 on 06/26/26 | 20.27 on 07/10/26 | 97.78 on 06/30/26 | ||
| 3-Month | |||||
| %Chg | +33.90% since 04/13/26 | +43.23% since 04/13/26 | +37.76% since 04/13/26 | ||
| Low | 11.76 on 05/19/26 | 14.11 on 04/14/26 | 53.62 on 06/01/26 | ||
| High | 17.86 on 06/26/26 | 20.27 on 07/10/26 | 97.78 on 06/30/26 | ||
| 6-Month | |||||
| %Chg | +32.46% since 01/13/26 | -3.04% since 01/13/26 | +169.81% since 01/13/26 | ||
| Low | 11.71 on 03/24/26 | 12.89 on 03/27/26 | 30.96 on 01/14/26 | ||
| High | 17.86 on 06/26/26 | 21.23 on 01/15/26 | 97.78 on 06/30/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,480,816 | 5,990,235 | 5,099,983 | ||
| Shares Outstanding, K | 319,023 | 302,843 | 60,312 | ||
| Annual Sales | 3,018,760,000 | 1,342,160,000 | 0 | ||
| Annual Net Income | 72,060,000 | 158,210,000 | -105,430,000 | ||
| Last Quarter Sales | 722,520,000 | 320,190,000 | 0 | ||
| Last Quarter Net Income | 62,260,000 | 32,810,000 | -31,820,000 | ||
| 60-Month Beta | 1.26 | 0.78 | -0.35 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.27 on 05/07/26 | 0.13 on 05/07/26 | -0.48 on 05/13/26 | ||
| Earnings Date | 07/30/26 | 08/04/26 | 08/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 20.74 | 31.60 | 0.00 | ||